Joseph A. Goldman

Partner at Jones Day

Joseph A. Goldman

Joseph A. Goldman

Partner at Jones Day

Biography

Jones Day
Joseph A. Goldman (Joe)
Partner
Joe Goldman represents clients on a wide range of international and domestic tax matters. His principal focus is on structuring, negotiating, and documenting mergers and acquisitions, post-acquisition integration of global businesses, internal restructurings, and intellectual property licensing and planning, as well as related disputes with the IRS.

Joe spends a significant amount of time on the cross-border aspects of international taxation. He works with clients on restructuring their businesses to maximize tax efficiency by developing specialized planning for deferral, foreign tax credits, transfer pricing, and profit repatriation. Joe works extensively with clients in the pharmaceutical, chemical, energy, electronics, manufacturing, spirits, services, and automotive industries and adheres to aggressive timetables to maximize client business opportunities. Representative clients include Celgene, Dow Corning, Patron Spirits, Pfizer, and Timken.

Joe is a member of the American Bar Association (Taxation Section), the District of Columbia Bar, and the New York State Bar Association. He has lectured at conferences on numerous topics involving federal and international taxation. Recently, he lectured on the intersection between tax and intellectual property.

EXPERIENCE:
Latrobe to be acquired by Carpenter Technology for $558 million
Jones Day is advising Latrobe Specialty Metals, Inc. in its acquisition by Carpenter Technology Corporation for $558 million.

Celgene acquires Abraxis BioScience for $2.9 billion
Jones Day advised Celgene Corporation in its $2.9 billion merger with Abraxis BioScience Inc.

BioMarin acquires LEAD Therapeutics
Jones Day advised BioMarin Pharmaceutical, Inc. in connection with the acquisition of LEAD Therapeutics, Inc., a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.

Verity Instruments acquires IP for semiconductor manufacturing
Jones Day represented Verity Instruments of Texas in the acquisition of substantially all of the assets of Lexas Research of Dublin, Ireland.

Celgene buys Gloucester Pharmaceuticals for $640 million to bolster its anticancer drug pipeline
Jones Day advised Celgene Corporation in its acquisition of Gloucester Pharmaceuticals.

Timken sells needle roller bearings business to JTEKT
Jones Day advised The Timken Company in the $330 million sale of its needle roller bearings business, which primarily serves customers in the automotive original-equipment sector, to Japan's JTEKT Corporation.

Pfizer reaches agreement with Boehringer Ingelheim to divest animal health assets in connection with regulatory approval process
Jones Day represented Pfizer Inc. in its recently announced agreement with Boehringer Ingelheim to divest certain animal health assets in connection with the regulatory approval process associated with Pfizer's pending acquisition of Wyeth.

Celgene announces $2.9 billion acquisition of Pharmion
Jones Day advised Celgene Corporation in its $2.9 billion acquisition of Pharmion.

Pfizer acquires CovX Pharmaceuticals, a biopharmaceutical company
Jones Day advised Pfizer, Inc. in its acquisition of CovX Pharmaceuticals, a privately held biopharmaceutical company.

Pfizer acquires Encysive Pharmaceuticals Inc
Jones Day acted as tax counsel to Pfizer, Inc. in its $195 million acquisition of Encysive Pharmaceuticals Inc. announced on February 20.

Pfizer acquires Serenex, Inc
Jones Day acted as tax counsel to Pfizer, Inc. in its acquisition of Serenex, Inc., a privately-held biotechnology company.

Pfizer Inc. acquires CatapultGenetics, Pty., Ltd. and Bovigen, LLC
Jones Day acted as tax counsel to Pfizer, Inc. in its acquisition of two privately held market-leading livestock genomics companies, Catapult Genetics, Pty., Ltd., and Bovigen, LLC.

Timken Company acquires aircraft component manufacturer The Purdy Corp.
Jones Day advised The Timken Company in its $200 million acquisition of the assets of The Purdy Corp., a leading precision manufacturer and systems integrator for military and commercial aviation customers.

Verint Systems acquires Witness Systems for $950 million
Jones Day advised Verint Systems Inc. in its $950 million acquisition of Witness Systems, Inc.

Timken sells Latrobe Steel
Jones Day advised The Timken Company, a leading global manufacturer of highly engineered bearings, alloy steels, and related components and assemblies, in the $250 million sale of Latrobe Steel Company, a manufacturer and distributor of high-performance, iron based remelted alloy steels for aerospace, defense and other life-critical applications, to an investor group comprised of The Watermill Group, Hicks Holdings LLC and Sankaty Advisors.

Pfizer acquires Coley Pharmaceutical Group, Inc. for a total value of $164 million
Jones Day represented Pfizer, Inc. in its acquisition of Coley Pharmaceutical Group, Inc. , a publicly-held biopharmaceutical company based in Wellesley, Massachusetts, specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight cancers, allergy and asthma disorders, and autoimmune diseases.

Pfizer acquires PowderMed
Jones Day represented Pfizer in its acquisition of PowderMed Ltd., a privately held U.K. company specializing in the development of DNA-based vaccines.

Pfizer sells consumer healthcare business to Johnson & Johnson for $16.6 billion
Jones Day represented Pfizer, Inc., the world's largest pharmaceutical company, in the sale of its consumer healthcare business to Johnson & Johnson for $16.6 billion cash.

Celgene Corporation acquires API Manufacturing Facility in Europe
Jones Day acted as tax counsel to Celgene in its acquisition of API manufacturing facility from Siegfried Ltd.

Morgan Stanley underwrites follow-on public offering of Common Shares by Westport Innovations
Jones Day represented Morgan Stanley & Co. Incorporated, as underwriter and lead bookrunner, in connection with the $121.7 million follow-on public offering of Common Shares by Westport Innovations, Inc., a leading provider of high-performance, low-emission engine and fuel system technologies utilizing gaseous fuels.

PUBLICATIONS:
2002
Group Taxation in Belgium, France, Germany, Italy, Spain, the United Kingdom, and the United States - PDF Only

SPEAKING ENGAGEMENTS:
2009
Tax for the Non-Tax Lawyer, CLE Summit
San Diego, California


2007
2007 International Tax Planning for the U.S. Taxpayer, Tax Executives Institute
Dallas, Texas


2004
Global Tax Planning for Intangibles, Tax Executives Institute
Houston, Texas


2004
Intangibles Tax Planning, Tax Executives Institute
Dallas, Texas


2004
Cross-Border Finance, Tax Executives Institute
Dallas, Texas


Experience Highlights

Latrobe to be acquired by Carpenter Technology for $558 million

Celgene acquires Abraxis BioScience for $2.9 billion

Timken sells needle roller bearings business to JTEKT

Areas of Focus

Tax
International Taxation
Mergers & Acquisitions Taxation
Private Equity / Real Estate Taxation


Contact
jagoldman@jonesday.com
Washington
(T) +1.202.879.5437
(F) +1.202.626.1700
Education

New York University (LL.M. in Taxation); Columbia University (J.D. 1991; Articles Editor, Journal of Transnational Law); Yeshiva University (B.S. in Accounting magna cum laude 1988)

Bar Admissions

District of Columbia and New York

Overview
RelSci Relationships

2712

Relationships
RelSci Relationships are individuals Joseph A. Goldman likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at Jones Day

Relationship likelihood: Strong

Partner at Jones Day

Relationship likelihood: Strong

Partner at Jones Day

Relationship likelihood: Strong

Partner at Jones Day

Relationship likelihood: Strong

Partner at Jones Day

Relationship likelihood: Strong

Partner at Jones Day

Relationship likelihood: Strong

Partner at Jones Day

Relationship likelihood: Strong

Partner at Jones Day

Relationship likelihood: Strong

Partner at Jones Day

Relationship likelihood: Strong

Partner at Jones Day

Relationship likelihood: Strong

Paths to Joseph A. Goldman
Potential Connections via
Relationship Science
You
Joseph A. Goldman
Partner at Jones Day
Career History
Partner
Current

Jones Day LP provides legal services. The company's practice areas include banking and finance, capital markets, mergers & acquisitions, real estate, government regulations, tax, financial institutions litigation and regulation, business restructuring, and private equity. It offers services to the airlines, aviation, automotive, construction, energy, healthcare, insurance, media, pharmaceuticals and telecommunication industries. Jones Day was founded in March 1893 by Edwin J. Blandin and William Lowe Rice and is headquartered in Cleveland, Ohio.

Transactions
Details Hidden

Genomatica, Inc. purchases REG Life Sciences LLC from Renewable Energy Group, Inc.

Details Hidden

Konica Minolta, Inc., Innovation Network Corporation of Japan, Ltd., Ambry Genetics Corp. /Private Group purchase Ambry Genetics Corp.

Details Hidden

TDK Corp. purchases InvenSense, Inc.

Other Affiliations

Joseph A. Goldman is affiliated with Jones Day

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Joseph A. Goldman. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Joseph A. Goldman's profile does not indicate a business or promotional relationship of any kind between RelSci and Joseph A. Goldman.